Theoretical and Natural Science
- The Open Access Proceedings Series for Conferences
Vol. 4, 28 April 2023
* Author to whom correspondence should be addressed.
Currently, the prevention and control measures are routinely implemented, which is not exactly the same as the situation of SARS. This paper compares China's different epidemic prevention measures against SARS and COVID-19 by analyzing previous literature. Both SARS and COVID-19 employed similar strategies, such as centralized isolation and treatment and regular case screening of citizens, but the degree of implementation of strategies during SARS was less than ideal for COVID-19 due to the technical limitations of the time. Government regulation and the use of advanced technologies are critical to controlling infectious diseases. The protection strategies that have been implemented have effectively mitigated the damage to society caused by the epidemic.
comparison, quarantine, SARS, Prevention Measures, COVID-19
1. Feng Kong, Shiyuan Yi. (2022) Influence of “Four-early” Strategy on Infection Risk Prevention and Control in Hospital System in Major Public Health Emergencies – Based on the Comparison of SARS and COVID-19. Chinese Emergency Management.
2. Qinghao Wang, Jianzhang Luo. (2021). Research on Government Emergency Response Strategy——Analysis of Event Process Based on New Coronary Pneumonia Epidemic. Journal of Anhui Administration Institute (03),63-68. doi:10.13454/j.issn.1674-8638.2021.03.010.
3. Fei Huang, Guoxiang Zhao, Jianfeng He, Guanming Li & Junzhang Tian. (2013). Status and Prospect of Emergency Management of Infectious Disease Emergencies in China—From SARS to Human Infection with H7N9 Avian Influenza. China Emergency Management (06), 12-17.
4. Peng Liu & Xiao Zhong. (2022). Smart Surveillance Promotes Epidemic Outbreak Risk Management – Taking COVID-19 epidemic as Example. Journal of University of Sichuan (Philosophy and Social Sciences Edition)(04), 172-183.
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. Authors who publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open Access Instruction).